Search

Search Constraints

You searched for: Author/Creator Giraldo, Pilar

Search Results

1. A prospective, international phase 2 study of bortezomib retreatment in patients with relapsed multiple myeloma. (7th January 2013)

2. Age and dPCR can predict relapse in CML patients who discontinued imatinib: The ISAV study. Issue 10 (10th September 2015)

3. Analysis of predictors of response to ruxolitinib in patients with myelofibrosis in the phase 3b expanded-access JUMP study. Issue 4 (21st March 2021)

4. Bicyclic Derivatives of L‐Idonojirimycin as Pharmacological Chaperones for Neuronopathic Forms of Gaucher Disease. Issue 8 (18th April 2013)

5. Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program. Issue 5 (30th March 2015)

6. Characterization of Variants in the Glucosylceramide Synthase Gene and their Association with Type 1 Gaucher Disease Severity. Issue 10 (13th August 2013)

7. Comparing the safety and efficacy of ruxolitinib in patients with Dynamic International Prognostic Scoring System low‐, intermediate‐1‐, intermediate‐2‐, and high‐risk myelofibrosis in JUMP, a Phase 3b, expanded‐access study. Issue 4 (5th July 2021)

8. Demographics and patient characteristics of 1209 patients with Gaucher disease: Descriptive analysis from the Gaucher Outcome Survey (GOS). Issue 2 (12th December 2017)

9. Do chronic myeloid leukemia patients with late "warning" responses benefit from "watch and wait" or switching therapy to a second generation tyrosine kinase inhibitor?. Issue 11 (27th August 2014)